期刊文献+

血管缝合器缝合股动脉的血管并发症及其处理 被引量:7

The complication and management of suturing femoral arteries with suture mediated closure system
下载PDF
导出
摘要 目的 探讨血管缝合器缝合股动脉的血管并发症及其防治。方法 选择冠脉造影和 (或 )冠心病介入治疗 (PCI)后采用血管缝合器缝合股动脉病例 2 18例 ,观察其成功率及血管并发症。结果 股动脉血管缝合 2 18例 ,成功率为 91.3% ,出现小血肿并伤口感染仅 1例 ,发生率 0 .5 % ;无假性动脉瘤、血栓形成以及栓塞事件。结论 血管缝合器适用于冠脉造影和PCI术后股动脉血管的缝合止血 ,其成功率高 。 Objective To discuss the femoral vascular complications and management in the patients with coronary angiography (CAG) and percutaneous coronary intervention (PCI) after applying the Suture Mediated Closure System (SMCS).Methods We observed the successful rate and the vascular complications in patients treated with the SMCS. Results Two hundreds and eighteen patients were treated with the SMCS, obtaining the success rate of 91.3%. Complication involved only one hemotoma with femoral arterial infection ( 0.5%), but no pseudoaneurysm, no embolus formation and embolization.Conclusions The suture closure system used in coronary angiography and PCI has high successful rate and less vascular complications.
出处 《介入放射学杂志》 CSCD 2005年第2期132-134,共3页 Journal of Interventional Radiology
关键词 血管并发症 缝合器缝合 股动脉 冠心病介入治疗 并发症发生率 冠脉造影 假性动脉瘤 血管缝合器 方法选择 伤口感染 栓塞事件 血栓形成 缝合止血 动脉血管 功率 PCI Suture mediated closure system Coronary angiography Percutaneous coronary intervention Vascular complication Infection
  • 相关文献

参考文献8

  • 1Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and Ⅱb/Ⅲa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol, 2002,40:78-83.
  • 2Sesana M, Vaghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol, 2000, 12: 395-399.
  • 3Silber S. 10 years of arterial closure devices: a critical analysis of their use after PTCA.Z Kardiol, 2000, 89: 383-389.
  • 4Chamberlin JR, Lardi AB, McKeever LS, et al. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv, 1999, 47: 143-147.
  • 5Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol, 2001, 13: 354-362.
  • 6Geary K, Landers JT, Fiore W, et al. Management of infected femoral closure devices. Cardiovasc Surg, 2002, 10: 161-163.
  • 7Smith TP, Cruz CP, Moursi MM, et al. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg, 2001, 182: 658-662.
  • 8Johanning JM, Franklin DP, Elmore JR, et al. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg, 2001, 34: 983-985.

同被引文献37

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部